Published: 23 September 2026 | 6.00 AM
Last Updated: 23 September 2026 | 6.00 AM
IPO Snapshot
| Particulars | Details |
|---|---|
| Chanakya View | 🟡 Selective Apply |
| Overall Rating | ⭐⭐⭐☆☆ (3/5) |
| GMP Today | No reliable premium established as of September 23; monitor updates |
| Issue Size | Rs. 218.40 crore |
| Fresh Issue / OFS | Rs. 218.40 crore fresh issue; no OFS |
| Price Band | Rs. 123–130 per share |
| Lot Size | 115 shares |
| Minimum Retail Investment | Rs. 14,950 at the upper price |
| IPO Opens / Closes | September 28 / September 30, 2026 |
| Allotment / Listing | October 1 / October 6, 2026, tentative |
| Exchange | BSE and NSE |
| Lead Manager | Choice Capital Advisors Pvt. Ltd. |
| Registrar | KFin Technologies Ltd. |
Investor Decision Box
| Question | Chanakya View |
|---|---|
| Suitable for Listing Gain? | 🟡 Wait for subscription and a meaningful GMP trend |
| Suitable for Long-Term? | 🟡 Selectively, subject to execution and cash flows |
| Risk Level | Medium to high |
| Business Quality | ⭐⭐⭐⭐☆ |
| Financial Strength | ⭐⭐⭐☆☆ |
| Balance Sheet | ⭐⭐⭐☆☆ |
👉 | IPO GMP|IPO Reviews |IPO Subscription|IPO Allotment
Chanakya View
SRIT India has a long operating history in government and enterprise technology projects. Its order book provides revenue visibility, while healthcare, electronic governance and broadband offer multiple sources of demand. At Rs. 130, the stated post-issue P/E is 20.97 times, which calls for continued earnings growth.
The principal concern is execution: large technology contracts can tie up cash while projects are delivered and payments collected. The company proposes to allocate Rs. 124 crore of IPO proceeds to working capital. Borrowings also rose between FY24 and FY25.
Chanakya Recommendation: 🟡 Selective Apply. Review the final prospectus, subscription response and cash-flow position before applying. There is presently no dependable GMP signal for listing gains.
About the Company
Bengaluru-based SRIT India provides customised software development, systems integration and digital transformation services. Its three principal areas are healthcare, electronic governance, and telecommunications and broadband. Projects include health information systems, e-prescription platforms, supply-management systems and online licensing solutions.
The company serves government bodies, public-sector organisations and private enterprises. As of September 30, 2025, its reported outstanding order book was approximately Rs. 1,280.62 crore. An order book indicates contracted work; it does not guarantee the timing of revenue or cash collection.
Why This IPO Stands Out
✅ Approximately 26 years of operating experience in technology services.
✅ Projects span healthcare, government systems and connectivity.
✅ Reported order book is substantial relative to recent annual income.
✅ Entire issue is fresh capital, so proceeds go to the company.
✅ Post-issue market capitalisation is estimated at Rs. 835.53 crore at the upper price.
Key Risks
⚠ Government projects may face tender delays, implementation hurdles or slow collections.
⚠ Working capital needs could remain high despite fresh funding.
⚠ Order-book conversion depends on project execution and customer acceptance.
⚠ FY25 profit grew more slowly than income, requiring attention to margins.
⚠ GMP is presently insufficient to support a listing-gain case.
Financial Snapshot (Rs. Crore)
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| Total Income | 400.50 | 282.22 | 162.93 |
| EBITDA | 49.81 | 40.99 | 22.51 |
| Profit After Tax | 33.60 | 29.08 | 15.04 |
| Net Worth | 93.17 | 80.47 | 51.30 |
| Borrowings | 61.84 | 24.83 | 17.60 |
Chanakya Interpretation
FY25 total income rose about 42%, while profit after tax increased about 16%. Growth is evident, but the rise in borrowings and slower profit growth make cash conversion and project margins important checks. The supplied IPO data also reports Rs. 237.52 crore income and Rs. 19.92 crore profit for the six months ended September 2025; those figures are not a full-year comparison.
Business Quality Score
| Parameter | Rating |
|---|---|
| Business Model | ⭐⭐⭐⭐☆ |
| Industry Outlook | ⭐⭐⭐⭐☆ |
| Financial Performance | ⭐⭐⭐☆☆ |
| Management and Execution | ⭐⭐⭐☆☆ |
| Balance Sheet | ⭐⭐⭐☆☆ |
| Growth Potential | ⭐⭐⭐⭐☆ |
IPO Proceeds and Why They Matter
| Purpose | Amount |
|---|---|
| Modernisation and redevelopment of existing products | Rs. 15.36 crore |
| Working capital | Rs. 124 crore |
| Acquisitions, strategic initiatives and general corporate purposes | Balance amount |
Working capital is the largest specified use of proceeds. It could help SRIT India deliver projects while meeting staffing, development and other operating costs before customer payments arrive. Investors should monitor whether the fresh capital improves collections and cash generation. No specific acquisition has been identified.
Business Outlook
SRIT India works across healthcare, electronic governance, and telecommunications and broadband. Its reported order book offers potential revenue visibility, but contracts must be delivered, accepted and paid for before they translate into cash.
The Rs. 15.36 crore allocation for product modernisation could help the company improve existing platforms and compete for future projects. Growth will depend on timely execution, margins on new contracts and disciplined bidding, particularly where government customers are involved.
Strengths vs Concerns
| 👍 Strengths | ⚠ Concerns |
|---|---|
| Experience delivering large technology projects | Delays can affect project completion and payment |
| Healthcare and government technology capabilities | Working capital absorbs substantial IPO proceeds |
| Reported order book supports visibility | Order book is not guaranteed revenue |
| Fresh issue brings capital into the company | Proposed acquisitions are not yet identified |
Who Should Apply?
| Investor Type | Suitability |
|---|---|
| Listing Gain Investors | ⭐⭐☆☆☆ — wait for a meaningful GMP and subscription trend |
| Long-Term Investors | ⭐⭐⭐☆☆ — suitable for selective consideration |
| Conservative Investors | ⭐⭐☆☆☆ — monitor cash flows after listing |
| Investors Comfortable With Project Risk | ⭐⭐⭐⭐☆ — assess execution closely |
Chanakya Final Verdict
SRIT India offers exposure to digital systems used by government and enterprise customers. Its reported order book and fresh capital provide a basis for growth, while the upper-band post-issue P/E of 20.97 times requires continued delivery of earnings. The heavy working-capital allocation makes cash collection a key measure of success. With no dependable GMP trend yet, a listing-gain call would be premature. Chanakya Recommendation: 🟡 Selective Apply, subject to the final offer document, subscription demand and evidence that projects convert into profitable cash flows.
Frequently Asked Questions
Should investors apply for the SRIT India IPO?
Chanakya’s current view is Selective Apply. Review subscription demand and the final issue documents before deciding.
How will SRIT India use the IPO proceeds?
It specifies Rs. 124 crore for working capital and Rs. 15.36 crore for product modernisation, with the balance covering other stated purposes.
Is the SRIT India IPO suitable for listing gains?
A dependable GMP trend has not yet emerged. Listing-gain investors should wait for stronger evidence of demand.
Summary
The Rs. 218.40 crore SRIT India IPO is entirely a fresh issue. Its investment case rests on converting technology contracts into earnings and cash; Selective Apply remains the current view.